Chronic eosinophilic leukemia with erythroblastic proliferation and the rare translocation t(8;9)(p22;p24) with PCM1-JAK2 fusion gene: a distinct clinical, pathological and genetic entity with potential treatment target?

MeSH terms

• Antineoplastic Agents / therapeutic use
• Cell Proliferation
• Chromosomes, Human, Pair 8 / genetics
• Chromosomes, Human, Pair 9 / genetics
• Chronic Disease
• Diagnosis, Differential
• Erythroblasts / pathology*
• Female
• Humans
• Hydroxyurea / therapeutic use
• Hypereosinophilic Syndrome / diagnosis*
• Hypereosinophilic Syndrome / drug therapy
• Infant, Newborn
• Interferon-alpha / therapeutic use
• Oncogene Proteins, Fusion / genetics*
• Pregnancy
• Pregnancy Complications, Hematologic / diagnosis
• Pregnancy Complications, Hematologic / drug therapy
• Pregnancy Complications, Hematologic / genetics
• Pregnancy Complications, Neoplastic / diagnosis
• Pregnancy Complications, Neoplastic / drug therapy
• Pregnancy Complications, Neoplastic / genetics
• Translocation, Genetic*
• Treatment Outcome
• Young Adult